LOTTE Biologics Set to Engage in Critical Partnerships During DCAT Week 2026 in New York LOTTE Biologics will attend DCAT Week 2026 in New York to connect with potential partners in the pharmaceutical and biotechnology sectors.

LOTTE Biologics Set to Engage in Critical Partnerships During DCAT Week 2026 in New York #USA #New_York #LOTTE_BIOLOGICS #Bio_Campus #DCAT_Week

Collaboration Between Rakuten Medical and LOTTE Biologics Enhances Global Oncology Manufacturing Rakuten Medical and LOTTE Biologics have partnered to boost biopharmaceutical manufacturing for innovative oncology therapies, enhancing global cancer treatments.

Collaboration Between Rakuten Medical and LOTTE Biologics Enhances Global Oncology Manufacturing #South_Korea #Seoul #LOTTE_BIOLOGICS #Rakuten_Medical #Alluminox

Rakuten Medical and LOTTE Biologics Forge Partnership for Global Oncology Manufacturing Rakuten Medical and LOTTE Biologics have signed a manufacturing agreement aimed at boosting biopharmaceutical production in the global oncology market.

Rakuten Medical and LOTTE Biologics Forge Partnership for Global Oncology Manufacturing #United_States #San_Diego #LOTTE_BIOLOGICS #Rakuten_Medical #Alluminox

LOTTE BIOLOGICS Partners with Top U.S. Biopharmaceutical Firm LOTTE BIOLOGICS has formed a late-stage partnership with a leading U.S. biopharmaceutical company to enhance contract manufacturing capabilities, targeting patient access to innovative medicines.

LOTTE BIOLOGICS Partners with Top U.S. Biopharmaceutical Firm #South_Korea #Seoul #Biopharmaceutical #LOTTE_BIOLOGICS #Contract_Manufacturing

LOTTE BIOLOGICS Secures Key Manufacturing Partnership with U.S. Biopharmaceutical Company LOTTE BIOLOGICS has announced a significant contract manufacturing partnership with a leading U.S. biopharmaceutical firm to enhance global competitiveness.

LOTTE BIOLOGICS Secures Key Manufacturing Partnership with U.S. Biopharmaceutical Company #South_Korea #Seoul #LOTTE_BIOLOGICS #Global_Manufacturing #Biopharmaceutical_Partnership

LOTTE BIOLOGICS Expands Global Reach with New Contract Manufacturing Deal LOTTE BIOLOGICS has secured a manufacturing deal with Ottimo Pharma to produce antibody therapeutics, marking a significant milestone for the biopharmaceutical company.

LOTTE BIOLOGICS Expands Global Reach with New Contract Manufacturing Deal #South_Korea #Seoul #Ottimo_Pharma #LOTTE_BIOLOGICS #antibody_therapeutics

LOTTE BIOLOGICS and Ottimo Pharma Join Forces for Antibody Productivity LOTTE BIOLOGICS has established a manufacturing partnership with Ottimo Pharma for innovative antibody therapeutics, marking a key step in cancer treatment advancements.

LOTTE BIOLOGICS and Ottimo Pharma Join Forces for Antibody Productivity #South_Korea #Seoul #Ottimo_Pharma #LOTTE_BIOLOGICS #Antibody_Therapies

Lotte Biologics Enters Clinical Stage ADC Manufacturing Agreement with Asian Biotechnology Firm On April 24, Lotte Biologics signed a manufacturing agreement with an Asian biotechnology firm for clinical stage ADC candidates, signaling significant industry advancements.

Lotte Biologics Enters Clinical Stage ADC Manufacturing Agreement with Asian Biotechnology Firm #Japan #Tokyo #ADC #LOTTE_BIOLOGICS #James_Park

LOTTE BIOLOGICS Launches ADC Manufacturing Facility to Meet Growing Biotech Demands LOTTE BIOLOGICS has officially begun operations at its newly established ADC manufacturing facility, marking a significant milestone in its growth as a global CDMO.

LOTTE BIOLOGICS Launches ADC Manufacturing Facility to Meet Growing Biotech Demands #South_Korea #Seoul #LOTTE_BIOLOGICS #ADC_Manufacturing #Bio_Campus

LOTTE BIOLOGICS Announces Innovations at 2025 J.P. Morgan Healthcare Conference LOTTE BIOLOGICS showcased its latest advancements including SoluFlex Link at the prestigious J.P. Morgan Healthcare Conference, reinforcing its global CDMO ambitions.

LOTTE BIOLOGICS Announces Innovations at 2025 J.P. Morgan Healthcare Conference #South_Korea #Seoul #J.P._Morgan #LOTTE_BIOLOGICS #SoluFlex_Link